GB0330049D0 - The treatment of neuropathic pain conditions - Google Patents
The treatment of neuropathic pain conditionsInfo
- Publication number
- GB0330049D0 GB0330049D0 GBGB0330049.8A GB0330049A GB0330049D0 GB 0330049 D0 GB0330049 D0 GB 0330049D0 GB 0330049 A GB0330049 A GB 0330049A GB 0330049 D0 GB0330049 D0 GB 0330049D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- neuropathic pain
- pain conditions
- conditions
- neuropathic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/5545—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0330049.8A GB0330049D0 (en) | 2003-12-24 | 2003-12-24 | The treatment of neuropathic pain conditions |
PCT/GB2004/005408 WO2005060957A1 (fr) | 2003-12-24 | 2004-12-24 | Preparation de nefopam et utilisation de cette preparation pour le traitement de la douleur |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0330049.8A GB0330049D0 (en) | 2003-12-24 | 2003-12-24 | The treatment of neuropathic pain conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0330049D0 true GB0330049D0 (en) | 2004-02-04 |
Family
ID=31503197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0330049.8A Ceased GB0330049D0 (en) | 2003-12-24 | 2003-12-24 | The treatment of neuropathic pain conditions |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0330049D0 (fr) |
WO (1) | WO2005060957A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2937553B1 (fr) * | 2008-10-29 | 2011-01-07 | Biocodex | Combinaison synergique de composes analgesiques |
FR2940911B1 (fr) * | 2009-01-13 | 2012-09-21 | Philippe Perovitch | Formulation pour l'administration par voie trans-muqueuse buccale de molecules antalgiques et/ou anti-spasmodiques |
WO2011072394A1 (fr) | 2009-12-15 | 2011-06-23 | The Hospital For Sick Children | Procédé de traitement de cicatrices et de troubles à médiation par la β-caténine à l'aide de composés du néfopam |
US10736905B1 (en) | 2016-09-09 | 2020-08-11 | Shahin Fatholahi | Nefopam dosage forms and methods of treatment |
US10736874B1 (en) | 2017-09-08 | 2020-08-11 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
US11446311B2 (en) | 2017-09-08 | 2022-09-20 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
EP3679927A1 (fr) * | 2019-01-14 | 2020-07-15 | APTYS Pharmaceuticals SAS | Procédé de fabrication d'une composition pharmaceutique comprenant du néfopam et de l'acétaminophène et composition pharmaceutique ainsi obtenue |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020013331A1 (en) * | 2000-06-26 | 2002-01-31 | Williams Robert O. | Methods and compositions for treating pain of the mucous membrane |
GB0213869D0 (en) * | 2002-06-17 | 2002-07-31 | Arakis Ltd | The treatment of pain |
-
2003
- 2003-12-24 GB GBGB0330049.8A patent/GB0330049D0/en not_active Ceased
-
2004
- 2004-12-24 WO PCT/GB2004/005408 patent/WO2005060957A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005060957A1 (fr) | 2005-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2415378B (en) | Treatment of neurodegenerative conditions | |
GB2422373B (en) | Treatment of neurodegenerative conditions | |
EP1617844A4 (fr) | Traitement d'affections neurologiques | |
GB0213869D0 (en) | The treatment of pain | |
GB0211295D0 (en) | Treatment of pain | |
EP1653982A4 (fr) | Methode servant a traiter la mauvaise haleine | |
GB0330049D0 (en) | The treatment of neuropathic pain conditions | |
GB0300783D0 (en) | Treatment of neurodegenerative conditions | |
HK1087026A1 (en) | Use of indazole derivtives for the treatment of neuropathic pain | |
EP1687275A4 (fr) | Composes de pyridin-4-ylamine convenant pour le traitement de la douleur neuropathique | |
AU2003259074A8 (en) | Gal3 antagonists for the treatment of neuropathic pain | |
EP1691776A4 (fr) | Traitement du sida | |
GB0300428D0 (en) | Medical treatment | |
IL164951A0 (en) | The treatment of pain with lfendropil | |
HK1087027A1 (en) | Use of 2H-Ä1, 3Ü-oxazinoÄ3,2-AÜindole derivatives for the treatment of neuropathic pain | |
GB0322015D0 (en) | The treatment of neuropathic pain conditions | |
GB2409655B (en) | Treatment of fluids | |
GB0325957D0 (en) | The treatment of pain | |
GB0219706D0 (en) | The treatment of neuropathic pain | |
GB0327975D0 (en) | Methods of treatment | |
GB0322014D0 (en) | The treatment of pain | |
GB0211297D0 (en) | Pain treatment | |
GB0213870D0 (en) | The treatment of pain conditions | |
GB0216978D0 (en) | The treatment of pain | |
GB0418556D0 (en) | The treatment of pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |